康华生物 (300841.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(康华生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2020年一季报2019年年报2019年一季报2018年年报2018年三季报
上市前/上市后 上市前上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 115,451,776.73545,665,199.77110,604,477.99428,834,628.14245,273,353.26
 收到其他与经营活动有关的现金(元) 1,286,721.635,242,355.96744,351.9115,446,432.659,818,929.69
 经营活动现金流入小计(元) 116,738,498.36550,907,555.73111,348,829.90444,281,060.79255,092,282.95
 购买商品、接受劳务支付的现金(元) 6,232,639.4733,900,683.964,557,997.7135,306,472.5826,092,428.75
 支付给职工以及为职工支付的现金(元) 21,005,740.2850,055,286.4921,220,616.7944,218,131.0532,325,417.71
 支付的各项税费(元) 23,753,504.2048,352,432.5310,650,633.1548,011,912.9128,099,999.43
 支付其他与经营活动有关的现金(元) 61,835,684.47235,869,405.0354,253,280.20259,389,720.77159,443,222.11
 经营活动现金流出小计(元) 112,827,568.42368,177,808.0190,682,527.85386,926,237.31245,961,068.00
 经营活动产生的现金流量净额其他项目(元) ----7,598,700.00
 经营活动产生的现金流量净额(元) 3,910,929.94182,729,747.7220,666,302.0557,354,823.489,131,200.00
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 4,902.9166,091.2666,091.263,922.333,922.33
 投资活动现金流入小计(元) 4,902.9166,091.2666,091.263,922.333,922.33
 购建固定资产、无形资产和其他长期资产支付的现金(元) 21,561,774.3324,035,200.572,323,866.3234,580,561.4632,884,492.10
 投资活动现金流出小计(元) 21,561,774.3324,035,200.572,323,866.3234,580,561.4632,884,492.10
 投资活动产生的现金流量净额(元) -21,556,871.42-23,969,109.31-2,257,775.06-34,576,639.13-32,880,569.77
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---1,445,645.001,445,645.00
 取得借款收到的现金(元) -23,500,000.0013,500,000.0019,000,000.0019,000,000.00
 筹资活动现金流入小计(元) -23,500,000.0013,500,000.0020,445,645.0020,445,645.00
 偿还债务支付的现金(元) -32,500,000.0019,000,000.007,500,000.007,500,000.00
 分配股利、利润或偿付利息支付的现金(元) 109,958.33532,838.75178,865.365,941,644.905,733,696.78
 筹资活动现金流出小计(元) 109,958.3333,032,838.7519,178,865.3613,441,644.9013,233,696.78
 筹资活动产生的现金流量净额(元) -109,958.33-9,532,838.75-5,678,865.367,004,000.107,211,948.22
四、汇率变动对现金及现金等价物的影响
五、现金及现金等价物净增加额
 加:期初现金及现金等价物余额(元) 241,632,963.3392,356,582.4592,356,582.4562,575,024.8962,575,024.89
 期末现金及现金等价物余额(元) 223,879,079.36241,632,963.33105,080,127.3892,356,582.4546,039,943.89
补充资料:
 净利润(元) 64,875,672.75186,686,665.9635,531,437.37154,139,677.63141,814,700.00
 资产减值准备(元) -2,344,844.03208,703.887,022,053.913,193,700.00
 固定资产和投资性房地产折旧(元) 1,865,491.826,584,629.291,885,414.427,050,037.285,253,800.00
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 1,865,491.826,584,629.291,885,414.427,050,037.285,253,800.00
 无形资产摊销(元) 625,460.282,494,405.43624,727.922,289,697.861,698,000.00
 长期待摊费用摊销(元) 429,602.58924,648.03---
 处置固定资产、无形资产和其他长期资产的损失(元) 49,457.4920,533.71-40,648.796,284.626,300.00
 财务费用(元) 107,942.49484,257.53184,982.06442,271.79231,400.00
 递延所得税(元) 200,746.68337,097.13-300,449.10-240,069.33-5,700.00
  其中:递延所得税资产减少(元) 200,746.68337,097.13-300,449.10-240,069.33-5,700.00
 存货的减少(元) -7,025,776.36-16,036,476.66-938,012.57-6,337,154.06-9,689,200.00
 经营性应收项目的减少(元) -46,846,449.23-25,860,478.10-23,566,629.92-154,051,141.35-196,371,700.00
 经营性应付项目的增加(元) -14,052,478.914,486,497.28-2,636,852.3323,287,316.5455,401,200.00
 其他(元) 4,115,947.0820,263,124.097,915,282.8523,745,848.59-
 现金的期末余额(元) 223,879,079.36241,632,963.33105,080,127.3892,356,582.45-
 减:现金的期初余额(元) 241,632,963.3392,356,582.4592,356,582.4562,575,024.89-
 现金及现金等价物的净增加额(元) -17,753,883.97149,276,380.8812,723,544.9329,781,557.56-16,535,081.00
公告日期 2020-06-022020-06-022020-06-022019-05-102018-12-28
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院